Name Development Level Target Family
Name Description
dabigatran etexilate A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.
TCRDv4.6.9
DrugCentral Indication
DrugCentral
dabigatran etexilate